Almagate

Almagate
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
Oral
ATC code A02AD03 (WHO)
Identifiers
CAS Number 66827-12-1
PubChem (CID) 71749
ChemSpider 64792 YesY
UNII 568Z59H7ZJ YesY
KEGG D02821 YesY
Chemical and physical data
Formula Al2Mg6(OH)14(CO3)2 · 4 H2O
Molar mass 314.99 g/mol
3D model (Jmol) Interactive image
  (verify)

Almagate (trade name Almax) is an aluminium- and magnesium-containing antacid. It was first described in 1984.[1][2]

Adverse effects

Almagate is well tolerated. In a clinical trial, the most common adverse effects were diarrhea and nausea.[3]

References

  1. Moragues, J. B. (1984). "Characterization of a new crystalline synthetic gastric antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1346–1349. ISSN 0004-4172. PMID 6548918.
  2. Beneyto, J. F. B. (1984). "Evaluation of a new antacid, almagate" (Free full text). Arzneimittel-Forschung. 34 (10A): 1350–1354. ISSN 0004-4172. PMID 6439224.
  3. Suau, A. D.; Dominguez Martin, A; Ferrando Cucarella, J; Juncosa Iglesias, L; Muñoz Benitez, J; Nieto Calvet, M; Pérez Gieb, J; Pérez Mota, A; Pineda Garcia, A; Rodriguez Sanchez, E (1984). "Treatment of gastric pyrosis with almagate in patients with and without endoscopically demonstrable duodenal ulcer. A multicentre clinical trial" (Free full text). Arzneimittel-Forschung. 34 (10A): 1380–1383. ISSN 0004-4172. PMID 6548926.


This article is issued from Wikipedia - version of the 4/5/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.